Retardo en es it fr

Retardo Brand names, Retardo Analogs

Retardo Brand Names Mixture

  • No information avaliable

Retardo Chemical_Formula

C10H15N5

Retardo RX_link

No information avaliable

Retardo fda sheet

Retardo msds (material safety sheet)

Retardo Synthesis Reference

Shapiro, Freedman, U.S. pats. 2,961,377, 3,057,780 (1960, 1962 both to U.S.V.)

Retardo Molecular Weight

205.26 g/mol

Retardo Melting Point

175-178 oC

Retardo H2O Solubility

210 mg/mL

Retardo State

Solid

Retardo LogP

0.759

Retardo Dosage Forms

No information avaliable

Retardo Indication

For the reatment of type II diabetes mellitus.

Retardo Pharmacology

Used to treat diabetes, phenformin is a biguanide (contains 2 guanidino groups) hypoglycemic agent with actions and uses similar to those of metformin (Glucophage). Both drugs work by (1) decreasing the absorption of glucose by the intestines, (2) decreasing the production of glucose in the liver, and by (3) increasing the body's ability to use insulin more effectively. More specifically, phenformin improves glycemic control by improving insulin sensitivity. Phenformin is generally considered to be associated with an unacceptably high incidence of actic acidosis. In general biguanides should be used only in stable type II diabetics who are free of liver, kidney and cardiovascular problems and who cannot be controlled with diet.

Retardo Absorption

No information avaliable

Retardo side effects and Toxicity

No information avaliable

Retardo Patient Information

No information avaliable

Retardo Organisms Affected

Humans and other mammals